A Los Angeles chiropractor posed as a medical doctor and directed Medicare patients toward invasive artery procedures they ...

Discusses Phase III Data for Intismeran and Advances in Cancer Immunotherapy October 24, 2026 1:00 PM EDTCompany ...

Abbott's $7.4B free cash flow and 0.3x debt load contrast sharply with UnitedHealth's $16.1B free cash flow but higher leverage and government policy risk.

Adobe may be undervalued: see DCF fair value, upside scenarios, and how AI risks, Firefly, and its moat could shape long-term ...

A new review maps how RNA- and DNA-sensing innate immune pathways determine whether cardiotropic viral infection resolves or ...

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the vertical software stocks, including Manhattan ...

An ‘audit’ of the Bureau of Meteorology main dataset for measuring climate change claims it contains ‘widespread errors’. It doesn’t stack up ...

Virginia data centers face a new kWh tax, grid cost allocation, and flexibility demands that change siting, operations, and ...

Sofetabart mipitecan (Sofe-M) in combination with bevacizumab demonstrated a 79% confirmed objective response rate and 100% disease control rate, with ...

Goldman Sachs said this week there are plenty of top tech companies to buy heading into their quarterly results.

ZW191 demonstrates compelling anti-tumor activity in heavily pretreated patients with platinum-resistant ovarian cancer across folate receptor ...

The Ravens selected Cuevas with their second of three fifth-round picks, their second tight end of the draft following ...